AMFENAC SODIUM ANHYDROUS
UNII C20288EWAG

Substance Identification & Data

This profile provides standardized clinical and technical data for Amfenac Sodium Anhydrous, uniquely identified by the FDA Unique Ingredient Identifier (UNII) C20288EWAG.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 61941-56-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

C20288EWAG

CAS Registry Number

61941-56-8

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

AMFENAC SODIUM ANHYDROUS

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C15H12NO3.Na

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

MJAQSCHBMPGJES-UHFFFAOYSA-M

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C216635

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

23665728

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

c1(C(=O)c2ccccc2)c(c(CC([O-])=O)ccc1)N.[Na+]

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Amfenac Sodium Anhydrous. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.